JP2016523849A - 植物組成物とドセタキセルを使用する前立腺癌用併用療法 - Google Patents

植物組成物とドセタキセルを使用する前立腺癌用併用療法 Download PDF

Info

Publication number
JP2016523849A
JP2016523849A JP2016518420A JP2016518420A JP2016523849A JP 2016523849 A JP2016523849 A JP 2016523849A JP 2016518420 A JP2016518420 A JP 2016518420A JP 2016518420 A JP2016518420 A JP 2016518420A JP 2016523849 A JP2016523849 A JP 2016523849A
Authority
JP
Japan
Prior art keywords
prostate cancer
docetaxel
plant composition
extract
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016518420A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016523849A5 (enExample
Inventor
ダオ，ジェイムス
ダオ，ジェフリー
ジャーウィック，ウイリアム
ジャーウィック，レナ
ジョーダン，メリーアン
ウィルソン，レスリー
Original Assignee
ジェニアス バイオメド インターナショナル
ジェニアス バイオメド インターナショナル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジェニアス バイオメド インターナショナル, ジェニアス バイオメド インターナショナル filed Critical ジェニアス バイオメド インターナショナル
Publication of JP2016523849A publication Critical patent/JP2016523849A/ja
Publication of JP2016523849A5 publication Critical patent/JP2016523849A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
JP2016518420A 2013-06-03 2014-06-03 植物組成物とドセタキセルを使用する前立腺癌用併用療法 Pending JP2016523849A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361830626P 2013-06-03 2013-06-03
US61/830,626 2013-06-03
PCT/US2014/040769 WO2014197519A1 (en) 2013-06-03 2014-06-03 Combination therapy for prostate cancer using botanical compositions and docetaxel

Publications (2)

Publication Number Publication Date
JP2016523849A true JP2016523849A (ja) 2016-08-12
JP2016523849A5 JP2016523849A5 (enExample) 2017-07-13

Family

ID=52008544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016518420A Pending JP2016523849A (ja) 2013-06-03 2014-06-03 植物組成物とドセタキセルを使用する前立腺癌用併用療法

Country Status (7)

Country Link
US (1) US20160143971A1 (enExample)
EP (1) EP3003490B1 (enExample)
JP (1) JP2016523849A (enExample)
CN (1) CN105636647A (enExample)
CA (1) CA2951110A1 (enExample)
SG (1) SG11201510802QA (enExample)
WO (1) WO2014197519A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3630090A4 (en) * 2017-05-26 2021-04-07 Genyous Biomed International CANCER POLYTHERAPY USING PLANT COMPOSITIONS AND ENZALUTAMIDE
US10835538B2 (en) * 2018-03-28 2020-11-17 Nymox Corporation Method of treating benign prostatic hyperlasia with antibiotics
CN108836994B (zh) * 2018-07-25 2021-06-18 南京林业大学 一种人工林树皮皂苷类活性成分的提取方法
AR133093A1 (es) * 2023-06-30 2025-08-27 Future Biome Corp Mezclas de polisacáridos de ganoderma sessile, composiciones y métodos relacionados
CN117064899B (zh) * 2023-10-13 2024-01-23 暨南大学附属第一医院（广州华侨医院） 灵芝酸a在制备治疗去势抵抗性前列腺癌的药物中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505042A (ja) * 2003-09-08 2007-03-08 ジェニオウス バイオメド インターナショナル インコーポレイテッド 癌治療のための植物性薬品抽出物の組成物
JP2007505934A (ja) * 2003-09-22 2007-03-15 ジェニアス バイオメド インターナショナル インコーポレイテッド 癌治療のためのＨｉｐｐｏｐｈａｅｒｈａｍｎｏｉｄｅｓ組成物
US20110117121A1 (en) * 2006-10-27 2011-05-19 James Dao Compositions for treatment and inhibition of pain
WO2012061790A1 (en) * 2010-11-04 2012-05-10 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395770B1 (en) * 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US5910308A (en) 1997-03-19 1999-06-08 Sante International Inc. Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis
US6168795B1 (en) 1998-06-09 2001-01-02 Sant{acute over (e)} International Inc. Method for anticancer therapy using an herbal extract composition
US20050196409A1 (en) 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505042A (ja) * 2003-09-08 2007-03-08 ジェニオウス バイオメド インターナショナル インコーポレイテッド 癌治療のための植物性薬品抽出物の組成物
JP2007505934A (ja) * 2003-09-22 2007-03-15 ジェニアス バイオメド インターナショナル インコーポレイテッド 癌治療のためのＨｉｐｐｏｐｈａｅｒｈａｍｎｏｉｄｅｓ組成物
US20110117121A1 (en) * 2006-10-27 2011-05-19 James Dao Compositions for treatment and inhibition of pain
WO2012061790A1 (en) * 2010-11-04 2012-05-10 Genyous Biomed International Combination therapy for prostate cancer using botanical compositions and bicalutamide

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KIM SM, ET AL.: "Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells v", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 631, JPN6018012315, 6 January 2010 (2010-01-06), pages 1 - 9, ISSN: 0004062446 *
LEE SY, ET AL.: "Obovatol enhances docetaxel-induced prostate and colon cancer cell death through inactivation of nuc", JOURNAL OF PHARMACOLOGICAL SCIENCES, vol. 111, no. 2, JPN6018012314, 2009, pages 124 - 136, ISSN: 0004062445 *
NOGUCHI K, ET AL.: "Decrease in Prostate Specific Antigen Secretion Correlated with Docetaxel-Induced Growth Inhibition", 癌と化学療法, vol. 第３６巻，第１１号, JPN6018012313, November 2009 (2009-11-01), pages 1863 - 1870, ISSN: 0004062444 *
WATERHOUSE DN: "A novel combination of Chinese medicines to treat advanced cancers and lymphomas in rats", CHINESE MEDICINE [ONLINE], vol. 4:22, JPN6018012312, 2009, ISSN: 0004062443 *

Also Published As

Publication number Publication date
WO2014197519A1 (en) 2014-12-11
EP3003490A4 (en) 2017-01-25
EP3003490A1 (en) 2016-04-13
US20160143971A1 (en) 2016-05-26
CN105636647A (zh) 2016-06-01
EP3003490B1 (en) 2019-11-13
CA2951110A1 (en) 2014-12-11
SG11201510802QA (en) 2016-02-26

Similar Documents

Publication Publication Date Title
JP5300195B2 (ja) 癌治療のための植物性薬品抽出物の組成物
CN103327994B (zh) 一种组合物在制备用于治疗或降低受试者体内的前列腺癌的严重性的药物中的应用
EP3630090A1 (en) Combination therapy for cancer using botanical compositions and enzalutamide
KR101145248B1 (ko) 신생혈관형성 억제용 한약 조성물
Aqil et al. Anticancer phytocompounds: experimental and clinical updates
EP3003490B1 (en) Combination therapy for prostate cancer using botanical compositions and docetaxel
US20050214394A1 (en) Hippophae rhamnoides compositions for cancer therapy
CN105327071A (zh) 抗肿瘤的中药组合物及其用途
JP2016528178A (ja) 癌治療のための植物抽出物の新しい製剤
KR20240020687A (ko) 암의 예방 또는 치료를 위한 혼합 생약 추출물 및 도세탁셀의병용 요법
KR102186292B1 (ko) 혼합 생약 추출물 및 설파살라진을 유효성분으로 포함하는 대장염 예방 또는 치료용 조성물
Elsayed et al. A Comprehensive Review of Promising Phytoconstituents as Anti-Cancer Agents: Biological Mechanisms and Applications Across Different Cancers
KR101900802B1 (ko) 수치석웅황, 백화사설초 및 단삼을 포함하는 폐암 치료용 조성물
KR101434500B1 (ko) 검정콩으로부터 추출한 안토시아닌을 포함하는 전립선암의 예방 및 치료용 조성물
JP2017119677A (ja) 肺癌の治療に用いられる医薬組成物
HK1096855A (en) Compositions of botanical extracts for cancer therapy
Panneerselvan et al. T Potential of Herbal Medicines mmmS
HK1097420A (en) Hippophae rhamnoides compositions for cancer therapy
TW201722448A (zh) 用於治療乳癌之醫藥組合物
KR20130023175A (ko) 창출 추출물을 포함하는 췌장암 치료용 조성물 및 화장료 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170531

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180409

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180709

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180905

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190403

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20190403

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20190417

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20190520

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20190522

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20190628

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20190703

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20200127

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20200923

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20200930

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20201226

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210303

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210331

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210331